Pharmaceutical

Boehringer and CBmed partner to develop cancer therapies

Boehringer has entered a strategic collaboration with CBmed to expedite the translation of cancer treatment approaches into new therapies.

Feb 10, 2024 - 18:00
Boehringer and CBmed partner to develop cancer therapies
Boehringer has entered a strategic collaboration with CBmed to expedite the translation of cancer treatment approaches into new therapies.
Read the original article

Tags:

Previous Article

Janssen seeks EMA approval of RYBREVANT for NSCLC

Next Article

AstraZeneca posts 81% rise in FY 2023 profit after tax

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

What will it take to end health care worker burnout?

What will it take to end health care worker burnout?

Oct 26, 2023

STAT+: PBMs were the target of House hearing, but pharma wasn’t spared criticism

STAT+: PBMs were the target of House hearing, but pharm...

Sep 20, 2023

To fight bias against people with addiction, White House calls for ‘recovery-friendly’ workplaces

To fight bias against people with addiction, White Hous...

Nov 9, 2023